Cargando…

A Palmitoylethanolamide Producing Lactobacillus paracasei Improves Clostridium difficile Toxin A-Induced Colitis

Genetically engineered probiotics, able to in situ deliver therapeutically active compounds while restoring gut eubiosis, could represent an attractive therapeutic alternative in Clostridium difficile infection (CDI). Palmitoylethanolamide is an endogenous lipid able to exert immunomodulatory activi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esposito, Giuseppe, Corpetti, Chiara, Pesce, Marcella, Seguella, Luisa, Annunziata, Giuseppe, Del Re, Alessandro, Vincenzi, Martina, Lattanzi, Roberta, Lu, Jie, Sanseverino, Walter, Sarnelli, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111445/ https://www.ncbi.nlm.nih.gov/pubmed/33986673 http://dx.doi.org/10.3389/fphar.2021.639728

Ejemplares similares

Engineered Lactobacillus paracasei Producing Palmitoylethanolamide (PEA) Prevents Colitis in Mice
por: Esposito, Giuseppe, et al.
Publicado: (2021)

Oral Adelmidrol Administration Up-Regulates Palmitoylethanolamide Production in Mice Colon and Duodenum through a PPAR-γ Independent Action
por: Del Re, Alessandro, et al.
Publicado: (2022)

The potential of cannabidiol in the COVID‐19 pandemic
por: Esposito, Giuseppe, et al.
Publicado: (2020)

Ultramicronized Palmitoylethanolamide Inhibits NLRP3 Inflammasome Expression and Pro-Inflammatory Response Activated by SARS-CoV-2 Spike Protein in Cultured Murine Alveolar Macrophages
por: Del Re, Alessandro, et al.
Publicado: (2021)

Next-Generation Probiotics for Inflammatory Bowel Disease
por: Pesce, Marcella, et al.
Publicado: (2022)

HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia
por: Sarnelli, Giovanni, et al.
Publicado: (2018)

High-fat diet impairs duodenal barrier function and elicits glia-dependent changes along the gut-brain axis that are required for anxiogenic and depressive-like behaviors
por: Seguella, Luisa, et al.
Publicado: (2021)

Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion?
por: Esposito, Giuseppe, et al.
Publicado: (2020)

Impaired Duodenal Palmitoylethanolamide Release Underlies Acid-Induced Mast Cell Activation in Functional Dyspepsia
por: Sarnelli, Giovanni, et al.
Publicado: (2020)

Cannabidiol inhibits SARS‐Cov‐2 spike (S) protein‐induced cytotoxicity and inflammation through a PPARγ‐dependent TLR4/NLRP3/Caspase‐1 signaling suppression in Caco‐2 cell line
por: Corpetti, Chiara, et al.
Publicado: (2021)

Rifaximin Improves Clostridium difficile Toxin A-Induced Toxicity in Caco-2 Cells by the PXR-Dependent TLR4/MyD88/NF-κB Pathway
por: Esposito, Giuseppe, et al.
Publicado: (2016)

N-Palmitoyl-D-Glucosamine Inhibits TLR-4/NLRP3 and Improves DNBS-Induced Colon Inflammation through a PPAR-α-Dependent Mechanism
por: Palenca, Irene, et al.
Publicado: (2022)

Oral Immunization with Escherichia coli Nissle 1917 Expressing SARS-CoV-2 Spike Protein Induces Mucosal and Systemic Antibody Responses in Mice
por: Sarnelli, Giovanni, et al.
Publicado: (2023)

Nutraceuticals and Diet Supplements in Crohn’s Disease: A General Overview of the Most Promising Approaches in the Clinic
por: De Conno, Barbara, et al.
Publicado: (2022)

S100B Protein Stimulates Proliferation and Angiogenic Mediators Release through RAGE/pAkt/mTOR Pathway in Human Colon Adenocarcinoma Caco-2 Cells
por: Seguella, Luisa, et al.
Publicado: (2019)

Role of Enteric Glia as Bridging Element between Gut Inflammation and Visceral Pain Consolidation during Acute Colitis in Rats
por: Lucarini, Elena, et al.
Publicado: (2021)

Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner
por: Sarnelli, Giovanni, et al.
Publicado: (2016)

Endocannabinoid‐related compounds in gastrointestinal diseases
por: Pesce, Marcella, et al.
Publicado: (2017)

Leaky gut, dysbiosis, and enteric glia activation: the trilogy behind the intestinal origin of Parkinson’s disease
por: Seguella, Luisa, et al.
Publicado: (2019)

Dietary Lactobacillus fermentum and Lactobacillus paracasei improve the intestinal health of broilers challenged with coccidia and Clostridium perfringens
por: Li, Peng, et al.
Publicado: (2022)

Therapeutic effects of Lactobacillus paracasei subsp. paracasei NTU 101 powder on dextran sulfate sodium-induced colitis in mice
por: Chen, Chien-Li, et al.
Publicado: (2018)

Toxic megacolon in Clostridium difficile colitis
por: Fukui, Sayato, et al.
Publicado: (2023)

Pentamidine niosomes thwart S100B effects in human colon carcinoma biopsies favouring wtp53 rescue
por: Seguella, Luisa, et al.
Publicado: (2020)

Lactobacillus paracasei Reduces Intestinal Inflammation in Adoptive Transfer Mouse Model of Experimental Colitis
por: Oliveira, Manuel, et al.
Publicado: (2011)

Bench-to-bedside review: Clostridium difficile colitis
por: Gould, Carolyn V, et al.
Publicado: (2008)

Pseudomembranous Colitis: Not Always Caused by Clostridium difficile
por: Tang, Derek M., et al.
Publicado: (2014)

Hemolytic uremic syndrome and Clostridium difficile colitis
por: Keshtkar-Jahromi, Maryam, et al.
Publicado: (2012)

Non-clostridium difficile induced pseudomembranous colitis
por: Jagirdhar, Gowthami Sai Kogilathota, et al.
Publicado: (2023)

Nicotine Inhibits Clostridium difficile Toxin A-Induced Colitis but Not Ileitis in Rats
por: Vigna, Steven R.
Publicado: (2016)

Coculture Strategy for Developing Lactobacillus paracasei PS23 Fermented Milk with Anti-Colitis Effect
por: Lee, Kai-Yi, et al.
Publicado: (2021)

In vitro Study of Lactobacillus paracasei CNCM I-1518 in Healthy and Clostridioides difficile Colonized Elderly Gut Microbiota
por: Fehlbaum, Sophie, et al.
Publicado: (2019)

The Enterotoxicity of Clostridium difficile Toxins
por: Sun, Xingmin, et al.
Publicado: (2010)

The Risk Factors of Clostridium difficile Colitis in Colorectal Surgery
por: Yoo, Seung Jin
Publicado: (2010)

Clostridium difficile colitis – a serious current problem
por: Dumitru, Irina Magdalena, et al.
Publicado: (2013)

Blastocystis sp. Infection Mimicking Clostridium Difficile Colitis
por: Gil, Gaby S., et al.
Publicado: (2016)

Intravenous Immunoglobulin in the Treatment of Severe Clostridium Difficile Colitis
por: Shah, Nihar, et al.
Publicado: (2014)

Comparison of Fidaxomicin and Vancomycin for Recurrent Clostridium difficile Colitis
por: Khoo, Teresa, et al.
Publicado: (2017)

Acute Appendicitis: An Extracolonic Manifestation of Clostridium difficile Colitis
por: Ridha, Ali, et al.
Publicado: (2017)

Intraluminal Administration of Resiniferatoxin Protects against Clostridium difficile Toxin A-Induced Colitis
por: Vigna, Steven R.
Publicado: (2017)

Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1i15et9orqirprp11rle1v53su